Last year, these treatments accounted for 75% of the $236B in annual sales set to vanish with the loss of exclusivity.

Virtual screening methods fall broadly into two categories: ligand- and structure-based. Ligand-based virtual screening doesn’t require a target protein structure, Instead, it leverages known active ...

A new scalable technique enables the generation of human kidney organoids by integrating them into perfused pig kidneys.

Nanoparticles carrying IL-12 are non-toxic, elicit strong systemic antitumor immunity, and sensitize ovarian tumors to ICI therapy, a new study shows.

Virtual cell model development will be driven through tools, data, and benchmarks delivered through CZI’s virtual cells platform (VCP).

The study shows that communication between the entorhinal cortex and the hippocampus’s CA3 region helps mice form stable maps of places.

Using single-cell genomic sequencing, researchers identified somatic genetic mutations in the brains of CTE, RHI, and AD individuals.

Novo Nordisk has made an unsolicited, approximately up to $9 billion bid for Metsera—more than a month after Pfizer announced its intent to buy the company for up to $7.3 billion.

Chimera-511, a new, functionalized 3D chimeric protein, blends the benefits of fibrin and laminin gels for high hiPSC proliferation.

Simtra BioPharma expands globally, advancing sterile injectable manufacturing and biopharma innovation through strategic partnerships.

An academia-industry collaboration developed a new sampling algorithm for Design of Experiment intending to democratize experimental design.

Automation will help the cell therapy sector reduce production costs, resulting in lower-priced products that increase patient accessibility.